# PTC Therapeutics, Inc.: filings

PTCT · Nasdaq · CIK 1070081 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ptct.md) · [Financials](/companies/ptct/financials.md) · [Filings](/companies/ptct/filings.md) · [Insiders](/companies/ptct/insiders.md)

## Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 574, 144 204, 8-K 169, SC 13G/A 67, 10-Q 41, 3 39, SC 13G 28, DEFA14A 14, 10-K 13, DEF 14A 13, S-8 13, UPLOAD 13, SCHEDULE 13G/A 12, 424B5 11, CORRESP 10, CT ORDER 10, D 10, SC 13D/A 10, S-3ASR 8, ARS 5, POSASR 5, S-1/A 5, FWP 4, 8-K/A 3, SC 13D 3, SCHEDULE 13G 3, 3/A 2, 424B4 2, EFFECT 2, PRE 14A 2, S-1 2, S-1MEF 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 4/A 1, 5 1, 8-A12B 1, CERTNAS 1, DRS 1, DRS/A 1, RW 1, RW WD 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:31 ET | [10-Q](/filings/0001104659-26-120223.md) | Quarterly report, period 2026-09-30 | 0001104659-26-120223 |
| 2026-10-29 | 16:10 ET | [8-K](/filings/0001104659-26-120200.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120200 |
| 2026-09-21 | 16:34 ET | [8-K](/filings/0001070081-26-000023.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001070081-26-000023 |
| 2026-08-28 | 16:06 ET | [8-K](/filings/0001070081-26-000019.md) | 1.01 Entry into a material agreement | 0001070081-26-000019 |
| 2026-08-13 | 07:00 ET | [8-K](/filings/0001104659-26-095424.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-095424 |
| 2026-07-30 | 16:32 ET | [10-Q](/filings/0001070081-26-000017.md) | Quarterly report, period 2026-06-30 | 0001070081-26-000017 |
| 2026-07-30 | 16:05 ET | [8-K](/filings/0001070081-26-000016.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-26-000016 |
| 2026-06-18 | 16:14 ET | [8-K](/filings/0001104659-26-075731.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-075731 |
| 2026-06-16 | 07:00 ET | [8-K](/filings/0001104659-26-074292.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074292 |
| 2026-06-09 | 17:15 ET | [8-K](/filings/0001104659-26-071916.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-071916 |
| 2026-06-05 | 17:15 ET | [8-K](/filings/0001104659-26-071040.md) | 5.07 Shareholder vote results | 0001104659-26-071040 |
| 2026-05-07 | 16:32 ET | [10-Q](/filings/0001070081-26-000012.md) | Quarterly report, period 2026-03-31 | 0001070081-26-000012 |
| 2026-05-07 | 16:09 ET | [8-K](/filings/0001070081-26-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-26-000011 |
| 2026-04-28 | 16:29 ET | [8-K](/filings/0001070081-26-000006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-26-000006 |
| 2026-04-20 | 16:30 ET | [DEF 14A](/filings/0001104659-26-045528.md) | Proxy statement, period 2026-06-02 | 0001104659-26-045528 |
| 2026-03-25 | 09:00 ET | [8-K](/filings/0001104659-26-034207.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-034207 |
| 2026-02-19 | 16:36 ET | [10-K](/filings/0001104659-26-017575.md) | Annual report, period 2025-12-31 | 0001104659-26-017575 |
| 2026-02-19 | 16:14 ET | [8-K](/filings/0001104659-26-017546.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-017546 |
| 2026-02-12 | 17:10 ET | [8-K](/filings/0001104659-26-014414.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-014414 |
| 2026-01-12 | 12:00 ET | [8-K](/filings/0001104659-26-002799.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002799 |
| 2025-12-29 | 16:05 ET | [8-K](/filings/0001104659-25-124837.md) | 1.01 Entry into a material agreement | 0001104659-25-124837 |
| 2025-11-04 | 16:33 ET | [10-Q](/filings/0001070081-25-000028.md) | Quarterly report, period 2025-09-30 | 0001070081-25-000028 |
| 2025-11-04 | 16:10 ET | [8-K](/filings/0001070081-25-000026.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000026 |
| 2025-08-19 | 08:10 ET | [8-K](/filings/0001558370-25-011658.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011658 |
| 2025-08-07 | 16:36 ET | [10-Q](/filings/0001558370-25-010796.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010796 |
| 2025-08-07 | 16:30 ET | [8-K](/filings/0001558370-25-010786.md) | 1.01 Entry into a material agreement | 0001558370-25-010786 |
| 2025-08-07 | 16:17 ET | [8-K](/filings/0001558370-25-010770.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010770 |
| 2025-07-28 | 17:04 ET | [8-K](/filings/0001558370-25-009663.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009663 |
| 2025-06-17 | 17:00 ET | [8-K](/filings/0001558370-25-008694.md) | 5.07 Shareholder vote results | 0001558370-25-008694 |
| 2025-05-06 | 16:34 ET | [10-Q](/filings/0001070081-25-000019.md) | Quarterly report, period 2025-03-31 | 0001070081-25-000019 |
| 2025-05-06 | 16:03 ET | [8-K](/filings/0001070081-25-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000018 |
| 2025-05-05 | 07:55 ET | [8-K](/filings/0001070081-25-000014.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000014 |
| 2025-04-30 | 16:30 ET | [DEF 14A](/filings/0001558370-25-006007.md) | Proxy statement, period 2025-06-17 | 0001558370-25-006007 |
| 2025-03-28 | 11:12 ET | [8-K](/filings/0001104659-25-029124.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029124 |
| 2025-02-27 | 16:32 ET | [10-K](/filings/0001070081-25-000012.md) | Annual report, period 2024-12-31 | 0001070081-25-000012 |
| 2025-02-27 | 16:10 ET | [8-K](/filings/0001070081-25-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000011 |
| 2025-01-13 | 14:00 ET | [8-K](/filings/0001070081-25-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000007 |
| 2025-01-03 | 16:27 ET | [8-K](/filings/0001070081-25-000004.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001070081-25-000004 |
| 2024-12-02 | 07:15 ET | [8-K](/filings/0001070081-24-000029.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000029 |
| 2024-11-27 | 07:08 ET | [8-K](/filings/0001070081-24-000026.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000026 |
| 2024-11-07 | 16:35 ET | [10-Q](/filings/0001070081-24-000023.md) | Quarterly report, period 2024-09-30 | 0001070081-24-000023 |
| 2024-11-07 | 16:14 ET | [8-K](/filings/0001070081-24-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000021 |
| 2024-10-18 | 06:35 ET | [8-K](/filings/0001558370-24-013387.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013387 |
| 2024-08-27 | 16:45 ET | [SC 13D/A](/filings/0001104659-24-093470.md) | Ownership report, active investor, amended | 0001104659-24-093470 |
| 2024-08-08 | 16:35 ET | [10-Q](/filings/0001070081-24-000017.md) | Quarterly report, period 2024-06-30 | 0001070081-24-000017 |
| 2024-08-08 | 16:06 ET | [8-K](/filings/0001070081-24-000015.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000015 |
| 2024-06-28 | 07:00 ET | [8-K](/filings/0001070081-24-000010.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000010 |
| 2024-06-20 | 07:55 ET | [8-K](/filings/0001558370-24-009313.md) | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-009313 |
| 2024-05-20 | 07:20 ET | [8-K](/filings/0001558370-24-008446.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008446 |
| 2024-04-26 | 16:30 ET | [DEF 14A](/filings/0001558370-24-005924.md) | Proxy statement, period 2024-06-18 | 0001558370-24-005924 |

Page 1 of 6. [Older](/companies/ptct/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:45 ET. No prices; not investment advice.